Creditor Relations

Our bonds basically serve to raise long-term funds and thus form a solid financing basis for sustainable positive corporate development.

support_agent

Your contact persons

Stephanie Lemke

Senior Investor Relations Manager

Sustainability and Fast Growth

Sustainability and growth are key aspects of our Company’s strategy. This philosophy is also reflected in our diversified financing concept as we strive to be a trustworthy and stable partner for our investors. This is also why our bonds are generally used to raise long-term funds and thus provide a sound financing basis for a long-term positive development of our Company.


Trustful dialog

Financing Strategy

High Yield Bonds
Issuer
CHEPLAPHARM Arzneimittel GmbH
Amount
EUR 725,000,000.00
Release
10 May 2023
Maturity
15 May 2030
Ranking
Senior Secured 
Coupon
7.500%
Interest payment dates
15 May / 15 November - semi-annually
ISIN
XS2618867159
WKN
A351TE
Governing Law
New York Law
High Yield Bonds
Issuer
CHEPLAPHARM Arzneimittel GmbH
Amount
EUR 325,000,000.00
Release
10 May 2023
Maturity
15 May 2030
Ranking
Senior Secured (Floating Rate)
Coupon
3-month EURIBOR (0% Floor) + 4.75%
Interest payment dates
15 February / 15 May / 15 August / 15 November
ISIN
XS2618840974
WKN
A351TF
Governing Law
New York Law
High Yield Bonds
Issuer
CHEPLAPHARM Arzneimittel GmbH
Amount
USD 500,000,000.00
Release
15 October 2020
Maturity
15 January 2028
Ranking
Senior Secured
Coupon
5.500%
Interest payment dates
15 January / 15 July - semi-annually
ISIN
USD1T29ZAB81
WKN
A3H2YN
Governing Law
New York Law
High Yield Bonds
Issuer
CHEPLAPHARM Arzneimittel GmbH
Amount
EUR 500,000,000.00
Release
11 February 2020
Maturity
11 February 2027
Ranking
Senior Secured
Coupon
3.50%
Interest payment dates
15 February / 15 August - semi-annually
ISIN
XS2112973107
WKN
A254SJ
Governing Law
New York Law
High Yield Bonds
Issuer
CHEPLAPHARM Arzneimittel GmbH
Amount
EUR 575,000,000.00
Release
15 October 2020
Maturity
15 January 2028
Ranking
Senior Secured
Coupon
4.375%
Interest payment dates
15 January / 15 July - semi-annually
ISIN
XS2243548273
WKN
A3H2YL
Governing Law
New York Law
Term Loan B
Issuer
CHEPLAPHARM Arzneimittel GmbH
Amount
EUR 1,480,000,000.00
Release
22 February 2022
Maturity
21 February 2029
Ranking
Senior Secured
Coupon
EURIBOR (0%Floor) +4,00%
Interest periods
one, three or six months
Governing Law
English Law
Agent
Deutsche Bank Luxembourg S.A.

Discovering Investor Relations

Investor Relations topics

Back to top expand_less